Table 1 Baseline characteristics of the study patients
Categorya | Total (n = 241) |
|---|---|
Age (years) | 60 [45.0–73.0] |
Female | 112 (46.5%) |
eGFR (mL/min/1.73 m2) | 70.0 [50.9–85.1] |
Unknown | 9 |
Number of severity risk factors | 3 [2–5] |
≥ 65 years of age | 104 (43.2%) |
Malignancy | 98 (40.7%) |
Chronic respiratory disease | 28 (11.6%) |
Chronic kidney disease | 80 (33.2%) |
Diabetes mellitus | 53 (22.0%) |
Hypertension | 104 (43.2%) |
Hyperlipidemia | 71 (29.5%) |
Cardiovascular disease | 53 (22.0%) |
Cerebrovascular disease | 15 (6.2%) |
Body mass index ≥ 30 kg/m2 | 15 (6.2%) |
Smoking habit (within the past 30 days and more than 100 cigarettes in a lifetime) | 20 (8.3%) |
Prior solid-organ transplant | 17 (7.1%) |
Late pregnancy | 3 (1.2%) |
Use of immunosuppressants (including cancer chemotherapy) | 104 (43.2%) |
HIV infection (CD4 < 200 cells/mm3) | 1 (0.4%) |
Hospitalized patients | 44 (18.3%) |
Vaccination status | |
0–1 | 44 (18.3%) |
≥ 2 | 170 (70.5%) |
Unknown | 27 (11.2%) |
Prescribed COVID-19 medication | |
NMV-r | 126 (52.3%) |
MOV | 115 (47.7%) |